Melanotan 2 Melanotan 1 and 2, while sharing similarities, are distinct in terms of structure, receptor affinity, potential research applications, safety, and approval status
Operating from July 1, 2026, through December 31, 2027, this temporary initiative acts as a "bridge" to a future, permanent Medicare model (the BALANCE Model)
GLP-1 medications work by mimicking the hormone that manages blood glucose levels, appetite and digestion
Serious allergic reaction: Rarely, swelling, rash, breathing trouble, or dizziness may happen and need emergency care
For more information, contact us or book an appointment online